Active Follow-up in Patients with Localized Prostate Cancer: Evaluation of Long-term Results
Journal Title: Нирки - Year 2013, Vol 2, Issue 4
Abstract
Among the clinical recommendations one of the standard approaches in the treatment of prostate cancer is active follow-up. For 13 years, under the supervision there were 85.7 % of patients. Overall 3-, 5- and 7-year survival rate was 93.2 ± 4.6 %, 70.8 ± 9.1 % and 50.9 ± 10.2 %, respectively. 14.3% of patients died due to comorbidities. The average time of survival was 136 months. These data substantiate the feasibility of active follow-up from medical, social and economic point of view. Optimal results can be achieved with the right selection, the criteria of which are: the level of prostate-specific antigen ≤ 10 ng/ml, Gleason grading score ≤ 6, age, multiple organ pathology.
Authors and Affiliations
S. O. Vozianov, V. M. Grygorenko, R. O. Danylets, A. V. Bardin, L. V. Pereta
Keywords
Related Articles
- EP ID EP229826
- DOI -
- Views 98
- Downloads 0
Diuretics and advanced features of nephroprotection
The most frequently used diuretics in nephrology, and the scheme and dosages used for their prescription are considered. Attention is focused on a new class of hypoglycemic drugs (gliflozins) that can provide nephroprote...
Acute Glomerulonephritis: Clinical and Pathologic Features (Case Report)
Clinical observation demonstrates the case of acute postinfectious glomerulonephritis with its histopathological features with the preexisting injury of renal tubules — cystic kidney disease of undefined type. The patien...
European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the share initiative
.
Proteomics and Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging as a Modern Diagnostic Tool in Kidney Diseases
As a result of the rapid evolution of modern science, we are continually improving our knowledge of disease pathogenesis and morphology on a daily basis. Due to the era of omics sciences, such as genomics, transcriptomic...
Nephrotic Syndrome or Paraneoplastic Nephropathy in Shereshevsky — Turner Syndrome?
.